2025 has been a tough year for electric vehicle stocks. Companies like Lucid Group and Tesla have seen their valuations plummet. Rivian's (RIVN 4.42%) decline hasn't been quite as steep, but that's because its stock was already trading at a deep discount compared to those competitors.
There are several good reasons why Rivian's valuation is so low, but its stagnating revenue growth tops the list. Looking ahead, however, there's reason to expect its sales growth should spike starting in 2026 thanks to one exciting factor.
Rivian has done a terrific job scaling up its electric vehicle business. The company currently has two luxury models in production, and while those vehicles were panned for reliability by testers from Consumer Reports, the magazine's customer surveys showed that Rivian owners were more satisfied with their vehicles than owners of any other brand. Last quarter, Rivian also achieved a positive gross margin for the first time -- a huge milestone on its path to long-term financial stability.
Still, the company's valuation remains significantly below competitors like Tesla and Lucid due to its lackluster sales growth estimates. And that may offer a huge opportunity to investors.
RIVN PS Ratio data by YCharts.
While analysts expect minimal sales growth from Rivian this fiscal year, there's good reason to believe that sales growth will pick up considerably starting in 2026. That's because Rivian expects to begin production of three new mass-market vehicles early next year, all of which should cost less than $50,000. Offering vehicles in that price range should be a huge inflection point for its business, at least if Tesla's history offers any indication. After Tesla launched its first mass-market vehicles -- the Model Y and Model 3 -- its sales went on to double and then triple in the years that followed.
Once Rivian's affordable models hit the market in 2026, I expect its sales growth will accelerate rapidly. This should occur across a 12-month to 24-month time frame. Analysts, meanwhile, usually focus their estimates on the next 12 months. That has helped create an opportunity for patient investors to get in on Rivian at a good price now.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。